Hasil Pencarian - Xiaomin Wan
- Menampilkan 1 - 20 hasil dari 30
- Ke Halaman Berikutnya
-
1
-
2
Cost-Effectiveness Analysis of Hepatic Arterial Infusion Chemotherapy of Infusional Fluorouracil, Leucovorin, and Oxaliplatin Versus Transarterial Chemoembolization in Patients Wit... oleh Haixia Zhang, Xiaohui Zeng, Ye Peng, Chongqing Tan, Xiaomin Wan
Diterbitkan 2022-04-01
Artikel -
3
The cost of treating advanced non-small cell lung cancer: estimates from the chinese experience. oleh Xiaohui Zeng, Jonathan Karnon, Siying Wang, Bin Wu, Xiaomin Wan, Liubao Peng
Diterbitkan 2012-01-01
Artikel -
4
-
5
-
6
-
7
Cost-effectiveness of first-line enfortumab vedotin in addition to pembrolizumab for metastatic urothelial carcinoma in the United States oleh Andong Li, Andong Li, Meiyu Wu, Meiyu Wu, Ouyang Xie, Ouyang Xie, Heng Xiang, Heng Xiang, Kehui Meng, Kehui Meng, Chongqing Tan, Chongqing Tan, Long Wang, Xiaomin Wan, Xiaomin Wan
Diterbitkan 2024-09-01
Artikel -
8
Dynamic zero-COVID strategy in controlling COVID-19 in Shanghai, China: A cost-effectiveness analysis oleh Chongqing Tan, Xia Luo, Zhen Zhou, Xiaohui Zeng, Xiaomin Wan, Lidan Yi, Qiao Liu
Diterbitkan 2023-06-01
Artikel -
9
-
10
Cost-effectiveness analysis of tislelizumab, nivolumab and docetaxel as second- and third-line for advanced or metastatic non-small cell lung cancer in China oleh Dongchu Zhou, Xia Luo, Zhen Zhou, Xiaohui Zeng, Xiaomin Wan, Chongqing Tan, Qiao Liu
Diterbitkan 2022-08-01
Artikel -
11
Cost-effectiveness analysis of adding ramucirumab to the first-line erlotinib treatment for untreated EGFR-mutated metastatic non-small cell lung cancer in China oleh Xiaohui Zeng, Xiaomin Wan, Liubao Peng, Qiao Liu, Chongqing Tan, Xia Luo, Lidan Yi
Diterbitkan 2020-11-01
Artikel -
12
-
13
Cost-Effectiveness of Pembrolizumab Plus Chemotherapy as First-Line Therapy for Advanced Oesophageal Cancer oleh Meiyu Wu, Meiyu Wu, Shuxia Qin, Shuxia Qin, Liting Wang, Liting Wang, Chongqing Tan, Chongqing Tan, Ye Peng, Ye Peng, Xiaohui Zeng, Xia Luo, Xia Luo, Lidan Yi, Lidan Yi, Xiaomin Wan, Xiaomin Wan
Diterbitkan 2022-05-01
Artikel -
14
Economic Evaluation of Dapagliflozin in the Treatment of Patients With Heart Failure: A Systematic Review oleh Meiyu Wu, Meiyu Wu, Shuxia Qin, Shuxia Qin, Liting Wang, Liting Wang, Chongqing Tan, Chongqing Tan, Ye Peng, Ye Peng, Xiaohui Zeng, Xia Luo, Xia Luo, Lidan Yi, Lidan Yi, Xiaomin Wan, Xiaomin Wan
Diterbitkan 2022-04-01
Artikel -
15
-
16
-
17
-
18
-
19
-
20